From: Prevalence of metabolic syndrome among patients with Schizophrenia in Palestine
Variable | N(%) or Mean ± SD | P value d (Cohen’s value) and/or OR (95CI) | Chi- Square value (X 2) Or t-test value | ||
---|---|---|---|---|---|
Total | Male | Female | |||
250 (100%) | 182 (73.8%) | 68 (27.2%) | |||
Age (years) | 41.9 ± 11.8 | 42.5 ± 11.5 | 40.3 ± 12.4 | 0.2a | |
d = 0.18 | −1.3 | ||||
Education | 0.4b | ||||
≤ School education | 213 (85.2%) | 153 (84.1) | 60 (88.2) | 1.4 (0.62 – 3.3) | |
College education | 37 (14.8%) | 29 (15.9) | 8 (11.8) | d = 0.18 | 0.68 |
Marital Status | <0.01 b | ||||
Married | 138 (55.2%) | 88 (48.4) | 50 (73.5) | 3 (1.6 – 5.5) | |
Single/Divorced | 112 (44.8%) | 94 (51.6) | 18 (26.5) | d = 0.61 | 12.7 |
Smoker | < 0.01 b | ||||
Yes | 153 (61.2%) | 55 (80.9) | 42 (23.1) | 14.1 (7 – 28.3) | |
No | 97 (38.8%) | 13 (19.1) | 140 (76.9) | d = 1.46 | 69.66 |
Occupation | 0.1 b | ||||
Not working | 219 (87.6%) | 156 (85.7) | 63 (92.6) | 2.1 (0.8 – 5.7) | |
Working | 31 (12.4%) | 26 (14.3) | 5 (7.4) | d = 0.41 | 2.2 |
Duration of psychiatric illness | 15.8 ± 9.3 | 16.2 ± 9.0 | 14.8 ± 9.9 | 0.3 a | |
d = 0.15 | −1.01 | ||||
Waist Circumference | < 0.01 b | ||||
Normal | 137 (54.4) | 124 (68.1%) | 12 (17.6%) | 0.1 (0.05 – 0.2) | |
Above Normal | 114 (45.6%) | 58 (31.9%) | 56 (82.4%) | d = −1.27 | 50.86 |
Systolic Blood Pressure | 124.2 ±14.4 | 125.1 ± 14.1 | 121.8 ± 15 | 0.1 a | −1.6 |
d = 0.23 | |||||
Diastolic Blood Pressure | 75.5 ± 10.8 | 76.4 ± 10.2 | 73 ± 12.1 | 0.04 a | −2.0 |
d = 0.3 | |||||
Triglycerides | 193.2 ± 180.2 | 187.3 ± 125.4 | 208.8 ± 279 | 0.5 a | 0.6 |
d = −0.1 | |||||
HDL-C | 44.9 ± 10.9 | 43.8 ± 11 | 46.4 ± 10.6 | 0.1 a | 1.7 |
d = −0.24 | |||||
FPG | 99.5 ± 47.5 | 96.6 ± 45.3 | 107.3 ± 52.6 | 0.1 a | 1.5 |
d = −0.2 | |||||
CPZeq | 436.9 ± 275.6 | 455.6 ± 283.7 | 386.8 ± 247.7 | 0.07 a | −1.9 |
d = 0.3 | |||||
Olanzapine/Clozapine | 0.9 b | ||||
Yes | 30 (12) | 22 (12.1) | 8 (11.8) | 1.2 (0.6 – 2.3) | 0.18 |
No | 220 (88) | 160 (87.9) | 60 (88.2) | d = 0.1 | |
Drug regimen | 0.1 b | ||||
Monotherapy | 124 (49.6) | 85 (46.7) | 39 (57.4) | 1.5 (0.9 – 2.7) | 2.2 |
Combination therapy | 126 (50.4) | 97 (53.3) | 29 (42.6) | d = 0.22 |